1h Free Analyst Time
Global Permanent Artificial Skin Market 2020-2024Speak directly to the analyst to clarify any post sales queries you may have.
The publisher has been monitoring the global permanent artificial skin market and it is poised to grow by USD 4.41 bn during 2020-2024, progressing at a CAGR of 19% during the forecast period. The report on the global permanent artificial skin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in R&D funding. In addition, availability of cost-effective treatment in developing countries is anticipated to boost the growth of the global permanent artificial skin market as well.
Market Segmentation
This global permanent artificial skin market is segmented as below:
End-User:
- Hospitals
- Other Healthcare Centers
Geographic Segmentation:
- North America
- Europe
- APAC
- ROW
Key Trends for global permanent artificial skin market growth
This study identifies availability of cost-effective treatment in developing countries as the prime reasons driving the global permanent artificial skin market growth during the next few years.
Prominent vendors in global permanent artificial skin market
The publisher provides a detailed analysis of around 25 vendors operating in the global permanent artificial skin market 2020-2024, including some of the vendors such as AVITA Medical Ltd., Aroa Biosurgery Ltd., Eucare Pharmaceuticals Pvt. Ltd., Integra LifeSciences Corp., Mallinckrodt Plc, MedSkin Solutions Dr. Suwelack AG, MiMedx Group Inc., Misonix Inc., Organogenesis Holdings Inc. and Smith & Nephew Plc .
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
Table of Contents
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global permanent artificial skin market 2020-2024: AVITA Medical Ltd., Aroa Biosurgery Ltd., Eucare Pharmaceuticals Pvt. Ltd., Integra LifeSciences Corp., Mallinckrodt Plc, MedSkin Solutions Dr. Suwelack AG, MiMedx Group Inc., Misonix Inc., Organogenesis Holdings Inc. and Smith & Nephew Plc.
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the availability of cost-effective treatment in developing countries."
According to the report, one of the major drivers for this market is the increase in r&d funding.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AVITA Medical Ltd.
- Aroa Biosurgery Ltd.
- Eucare Pharmaceuticals Pvt. Ltd.
- Integra LifeSciences Corp.
- Mallinckrodt Plc
- MedSkin Solutions Dr. Suwelack AG
- MiMedx Group Inc.
- Misonix Inc.
- Organogenesis Holdings Inc.
- Smith & Nephew Plc
